webinar
Oct. 27-28, 2025, Boston, MA, USA - Booth 114.
Read More

Acid-PEG2-SS-PEG2-acid

  CAS No.: 1807539-10-1   Cat No.: BADC-01007   Purity: ≥95.0% 4.5  

Acid-PEG2-SS-PEG2-acid is a cleavable ADC linker with PEG spacers and disulfide bonds, featuring terminal acid groups for flexible conjugation. Improves solubility and enables controlled drug release in antibody-drug conjugates.

Acid-PEG2-SS-PEG2-acid

Structure of 1807539-10-1

Quality
Assurance

Worldwide
Delivery

24/7 Customer
Support
Category
ADC Linker
Molecular Formula
C14H26O8S2
Molecular Weight
386.48
Shipping
Room temperature
Shipping
Store at -20 °C, keep in dry and avoid sunlight.

* For research and manufacturing use only. We do not sell to patients.

Size Price Stock Quantity
-- $-- In stock

Looking for different specifications? Click to request a custom quote!

Capabilities & Facilities

Popular Publications Citing BOC Sciences Products
Synonyms
4,7,14,17-Tetraoxa-10,11-dithiaicosanedioic acid
IUPAC Name
Canonical SMILES
C(COCCOCCSSCCOCCOCCC(=O)O)C(=O)O
InChI
InChI=1S/C14H26O8S2/c15-13(16)1-3-19-5-7-21-9-11-23-24-12-10-22-8-6-20-4-2-14(17)18/h1-12H2,(H,15,16)(H,17,18)
InChIKey
TZKZHEPGHNBGKD-UHFFFAOYSA-N
Density
1.3±0.1 g/cm3
Solubility
10 mm in DMSO
Flash Point
300.9±30.1 °C
Index Of Refraction
1.528
Vapor Pressure
0.0±3.4 mmHg at 25°C
Appearance
Solid
Shelf Life
-20°C 3 years powder; -80°C 2 years in solvent
Shipping
Room temperature
Storage
Store at -20 °C, keep in dry and avoid sunlight.
Boiling Point
573.9±50.0 °C at 760 mmHg
Form
Solid
Biological Activity
Acid-PEG2-SS-PEG2-acid is a cleavable 4 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs)[1] . In Vitro: ADCs are comprised of an antibody to which is attached an ADC cytotoxin through an ADC linker[1] .

Acid-PEG2-SS-PEG2-acid, a versatile bifunctional reagent, finds diverse applications in bioconjugation and drug delivery. Here are four key applications presented with high perplexity and burstiness://

Antibody-Drug Conjugates: Utilizing Acid-PEG2-SS-PEG2-acid, researchers forge a crucial link between therapeutic agents and antibodies to create potent antibody-drug conjugates (ADCs). These specialized conjugates target cancer cells with pinpoint accuracy, ushering in a new era of precision cytotoxic drug delivery. This targeted delivery strategy minimizes harm to healthy tissues while maximizing the efficacy of anti-cancer treatments.

Protein-Protein Crosslinking: Through the artful crosslinking of proteins, Acid-PEG2-SS-PEG2-acid facilitates in-depth exploration of protein interactions and intricate complex formations. By establishing robust disulfide bonds between proteins, scientists can dissect protein assemblies using cutting-edge tools like mass spectrometry and X-ray crystallography. This wealth of information is indispensable for unraveling the mysteries of protein functions and interplays within cellular dynamics.

Controlled Drug Release: Delving into the realm of drug delivery systems, Acid-PEG2-SS-PEG2-acid plays a pivotal role in engineering platforms with finely tuned release mechanisms. The sensitive disulfide linkage within this compound responds to the reductive milieu inside cells, orchestrating the precise release of therapeutic payloads at designated sites. This targeted drug release paradigm heightens treatment efficacy, narrowing the therapeutic window and diminishing adverse effects associated with systemic drug circulation.

Surface Modification: In the realm of material science, Acid-PEG2-SS-PEG2-acid emerges as a transformative tool for surface engineering of nanoparticles and diverse materials. By grafting functional moieties onto surfaces, researchers sculpt material properties to cater to biomedical applications such as precision drug delivery and biosensing. This tailored surface modification strategy elevates the biocompatibility and performance benchmarks of nanomaterials across a spectrum of cutting-edge applications.

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

Related Products

Contact our experts today for pricing and comprehensive details on our ADC offerings.

You May Also Be Interested In

From cytotoxin synthesis to linker design, discover our specialized services that complement your ADC projects.

ADC Linker Development Enzyme Cleavable Linker Cathepsin B Cleavable Linker/Peptide Linker Phosphatase Cleavable Linker β-Glucuronide Linker β-Galactosidase Cleavable Linker Sulfatase Cleavable Linker Chemically Cleavable Linker Non-Cleavable Linker Services Acid Cleavable Linker/Hydrazone Linker

Unlock Deeper ADC Insights

Learn more about payload design, linker strategies, and integrated CDMO support through our curated ADC content.

Linkers - A Crucial Factor in Antibody–Drug Conjugates In-Depth Review of ADC Linkers: Types, Mechanisms, and Research Progress New Structural Insights Solve Instability Issues of Maleimide Linkers in ADCs PEG Linkers in Antibody-Drug Conjugates Peptide Linkers in Antibody-Drug Conjugates Disulfide Linkers in Antibody-Drug Conjugates Biotinylation Reagents in Antibody-Drug Conjugates Maleimide Linkers in Antibody-Drug Conjugates Current ADC Linker Chemistry SPDB Linkers in Antibody-Drug Conjugates

Explore More ADC Products

Find exactly what your project needs from our expanded range of ADCs, offering flexible options to fit your timelines and goals.

ADC Cytotoxin

Powerful Targeted Cancer Solutions

ADC  Cytotoxin with Linker

Enhanced Stability And Efficacy

ADC Linker

Precise Conjugation For Success

Antibody-Drug  Conjugates (ADCs)

Maximized Therapeutic Performance

Auristatins

Next-Level Tubulin Inhibition

Calicheamicins

High-Impact DNA Targeting

Camptothecins

Advanced Topoisomerase Inhibition

Daunorubicins / Doxorubicins

Trusted Anthracycline Payloads

Duocarmycins

Potent DNA Alkylation Agents

Maytansinoids

Superior Microtubule Disruption

Pyrrolobenzodiazepines

Ultra-Potent DNA Crosslinkers

Traditional Cytotoxic Agents

Proven Chemotherapy Solutions

Cleavable Linker

Precise Intracellular Drug Release

Non-Cleavable Linker

Exceptional Long-Term Stability

Historical Records: Anetumab ravtansine | Maytansinoid B | Fmoc-PEG4-NHS ester | t-Boc-N-amido-PEG7-alcohol | m-PEG8-COOH | γ-Amanitin | 5-Maleimidovaleric acid | Boc-NH-ethyl-SS-propionic acid | Fmoc-NH-ethyl-SS-propionic acid | THP-SS-PEG1-Tos | Acid-PEG2-SS-PEG2-acid
Send Inquiry
Verification code
Inquiry Basket